Baidu
map

眼科

订阅

MedSci主页 / 所有栏目 / 眼科

Advanced Science：青光眼的新型疗法，无需药物或手术

2020-12-10 MedSci原创 MedSci原创

关注

眼压病理性升高是青光眼视神经损害的主要危险因素之一，降低眼压被证实的有效的治疗方法。目前，临床上主要治疗方式为滴眼剂以及外科手术等，但这些治疗方式疗效有限。近日，研究人员开发了一种非药物，非手术，长效

眼压病理性升高是青光眼视神经损害的主要危险因素之一，降低眼压被证实的有效的治疗方法。目前，临床上主要治疗方式为滴眼剂以及外科手术等，但这些治疗方式疗效有限。近日，研究人员开发了一种非药物，非手术，长效的治疗青光眼的新方法以控制眼压。研究结果发表在Advanced Science杂志上。

这种新的治疗方式是使用一根微小的空心针将一种天然聚合物制剂注射到眼表下方的脉络膜上腔 (SCS) 的结构中。在眼睛内部，该材料发生化学交联形成水凝胶，在SCS中打开一条通道，让房水通过另一个途径排出，从而降低眼压。

脉络膜上的水凝胶注射方案和研究设计概述

在这项研究中，研究人员通过动物模型进行试验，结果发现，向SCS注射以透明质酸(HA)为基础的水凝胶可降低兔眼眼压1个月以上，优化凝胶配方后可使眼压降低长达4个月。通过临床眼科检查的安全性评估表明，耐受性良好。组织病理学显示注射部位有轻微出血和纤维化。研究人员表示，随着技术的发展，后续有望将效果维持长达六个月。

脉络膜上水凝胶注射液对兔眼眼压（IOP）的影响

进一步分析表明，眼压降低与SCS扩张有很强的相关性。治疗眼和未治疗眼的压力依赖性流出的常规途径没有差异。

总之，SCS扩容与原位成形水凝胶可使眼压降低的时间延长，用于治疗眼高血压和青光眼，无需药物或手术。同时，该方法可以重复进行而不会伤害眼睛。在进入人体试验之前，该程序还必须在其他动物身上进行测试。

原始出处

J. Jeremy Chae et al, Drug‐Free, Nonsurgical Reduction of Intraocular Pressure for Four Months after Suprachoroidal Injection of Hyaluronic Acid Hydrogel, Advanced Science 2020. 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2022-01-03 ms3000000727805956

    厉害

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-04-22 1508842480_96220437

    #Advanced#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-04-30 MedSciZeng

    #Science#点击进入话题查看更多相关文章 或评论时插入话题加入讨论

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-09-06 smartjoy

    #新型疗法#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-03-17 330911029

    厉害

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2021-02-19 ms9000000303164655

    什么时候用到人身上阿

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2020-12-10 rayms

    青光眼患者**，希望尽快进入临床

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2020-12-23 ms1000000534935938

    思路可以

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2020-12-12 爆笑小医

    #SCIE#

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1180206, encodeId=8d6211802066b, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08af5472903, createdName=ms3000000727805956, createdTime=Mon Jan 03 22:38:58 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020058, encodeId=5f62202005856, content=<a href='/topic/show?id=8544202eff' target=_blank style='color:#2F92EE;'>#Advanced#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2027, encryptionId=8544202eff, topicName=Advanced)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Thu Apr 22 20:26:14 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=961947, encodeId=2fcc96194e4e, content=<a href='/topic/show?id=726a1600078' target=_blank style='color:#2F92EE;'>#Science#</a>点击进入话题查看更多相关文章 或评论时插入话题加入讨论, beContent=null, objectType=article, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16000, encryptionId=726a1600078, topicName=Science)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Fri Apr 30 17:35:14 CST 2021, time=2021-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1924880, encodeId=e2501924880d8, content=<a href='/topic/show?id=7d1558259f5' target=_blank style='color:#2F92EE;'>#新型疗法#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58259, encryptionId=7d1558259f5, topicName=新型疗法)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e76f39, createdName=smartjoy, createdTime=Mon Sep 06 20:26:14 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=948928, encodeId=8ec394892873, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae5a4682892, createdName=330911029, createdTime=Wed Mar 17 09:17:04 CST 2021, time=2021-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925506, encodeId=b01c92550660, content=什么时候用到人身上阿, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1c0b5426600, createdName=ms9000000303164655, createdTime=Fri Feb 19 17:12:36 CST 2021, time=2021-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906708, encodeId=de60906e08a5, content=青光眼患者**，希望尽快进入临床, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/6252e946e5ef413b86dc0f7d1f73b6db/9a7e8c88a38e487b8da4968a67bbd261.png, createdBy=b9f692910, createdName=rayms, createdTime=Thu Dec 10 14:57:40 CST 2020, time=2020-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=910317, encodeId=12cb91031e39, content=思路可以, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201118/68d39549b17540d1a860b9d81ab34778/2975f9542e0649e098b2897635114ff4.jpg, createdBy=8faa5429820, createdName=ms1000000534935938, createdTime=Wed Dec 23 11:37:21 CST 2020, time=2020-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376222, encodeId=61b413e622277, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Sat Dec 12 05:26:14 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907025, encodeId=453990e025b5, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210405/8cca360e910e4e4abbad67324b2cf9ef/37fef780c17a4da7b5506ea9971b725e.jpg, createdBy=91fa5404020, createdName=暂0e4516bm, createdTime=Fri Dec 11 12:46:39 CST 2020, time=2020-12-11, status=1, ipAttribution=)]
    2020-12-11 暂0e4516bm

    厉害

    0

以上为热门评论，梅斯医学App还有更多内容
Baidu
map
Baidu
map
Baidu
map